RECK Gene Polymorphisms Influence NSCLC Susceptibility, but not the Chemotherapy Response Status in Chinese Cohort

被引:5
作者
Chen, Xiaohui [1 ]
Jiang, Fusheng [2 ]
Shi, Ningchuan [1 ]
Zhou, Hui [1 ]
Zhang, Liang [1 ]
Chen, Yu [1 ]
Zheng, Yanhua [1 ]
Yan, Tian Guo [1 ]
机构
[1] Hangzhou Normal Univ, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Med Univ, Life Sci Coll, Hangzhou, Zhejiang, Peoples R China
关键词
Reversion-inducing cysteine-rich protein with Kazal motifs; Non-small cell lung cancer; Susceptibility; Chemotherapy; CELL LUNG-CANCER; CLINICOPATHOLOGICAL CHARACTERISTICS; CLINICAL-SIGNIFICANCE; BREAST-CANCER; EXPRESSION; DIAGNOSIS; PROGNOSIS; ANGIOGENESIS; METHYLATION; REGULATOR;
D O I
10.1007/s12013-014-9832-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To test the possible association between reversion-inducing cysteine-rich protein with Kazal motifs (RECK) genetic variants and susceptibility as well as the chemotherapy response status to in patients with advanced non-small cell lung cancer (NSCLC). We recruited 304 patients who were histologically diagnosed as advanced NSCLC (IIIa, IIIb, and IV stage) in our hospital from September 2003 to January 2008. We also enrolled 409 sex- and age-matched healthy volunteers as controls. RECK Gene Polymorphisms were determined. Only the genotype distributions and allele frequencies of rs10814325 T > C were significantly different between NSCLC and controls (both P < 0.001). By multivariate analyses, markedly higher risk for NSCLC was observed in rs10814325 CC genotype (adjusted OR = 2.302, P = 0.012, with TT as reference) after adjustment with age, sex, smoking status, histology, differentiation, and stage. Haplotypes analyses showed that the A(rs11788747)-G(rs16932912)-C-rs10814325 and A(rs11788747)-A(rs16932912A)-C-rs10814325 were associated with higher risk for NSCLC; however, G(rs11788747)-G(rs16932912)-T-rs10814325 and G(rs11788747)-A(rs16932912)-T-rs10814325 haplotypes showed significantly protective roles in the NSCLC risk. The genotype and the allele frequencies of RECK gene were not significantly different between chemotherapy responder and non-responders. Multivariate logistic regression analysis showed no association between the RECK polymorphism and chemotherapy response status in this study. To the best of our knowledge, this is the first study documenting the etiological role of RECK genetic polymorphisms in NSCLC.
引用
收藏
页码:567 / 571
页数:5
相关论文
共 24 条
  • [11] The β1-Integrin-Dependent Function of RECK in Physiologic and Tumor Angiogenesis
    Miki, Takao
    Shamma, Awad
    Kitajima, Shunsuke
    Takegami, Yujiro
    Noda, Makoto
    Nakashima, Yasuaki
    Watanabe, Ken-ichiro
    Takahashi, Chiaki
    [J]. MOLECULAR CANCER RESEARCH, 2010, 8 (05) : 665 - 676
  • [12] The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis
    Oh, J
    Takahashi, R
    Kondo, S
    Mizoguchi, A
    Adachi, E
    Sasahara, RM
    Nishimura, S
    Imamura, Y
    Kitayama, H
    Alexander, DB
    Ide, C
    Horan, TP
    Arakawa, T
    Yoshida, H
    Nishikawa, SI
    Itoh, Y
    Seiki, M
    Itohara, S
    Takahashi, C
    Noda, M
    [J]. CELL, 2001, 107 (06) : 789 - 800
  • [13] Safety and prognosis of limited surgery for octogenarians with non-small-cell lung cancer
    Okada A.
    Hirono T.
    Watanabe T.
    [J]. General Thoracic and Cardiovascular Surgery, 2012, 60 (2) : 97 - 103
  • [14] Diagnosis and management of early lung cancer
    Park, BJ
    Altorki, NK
    [J]. SURGICAL CLINICS OF NORTH AMERICA, 2002, 82 (03) : 457 - +
  • [15] RECK overexpression decreases invasive potential in prostate cancer cells
    Rabien, Anja
    Erguen, Bettina
    Erbersdobler, Andreas
    Jung, Klaus
    Stephan, Carsten
    [J]. PROSTATE, 2012, 72 (09) : 948 - 954
  • [16] Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung
    Raponi, Mitch
    Zhang, Yi
    Yu, Jack
    Chen, Guoan
    Lee, Grace
    Taylor, Jeremy M. G.
    MacDonald, James
    Thomas, Dafydd
    Moskaluk, Christopher
    Wang, Yixin
    Beer, David G.
    [J]. CANCER RESEARCH, 2006, 66 (15) : 7466 - 7472
  • [17] SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci
    Shi, YY
    He, L
    [J]. CELL RESEARCH, 2005, 15 (02) : 97 - 98
  • [18] Reversion-inducing cysteine-rich protein with Kazal motif (RECK) expression: an independent prognostic marker of survival in colorectal cancer
    Stenzinger, Albrecht
    von Winterfeld, Moritz
    Rabien, Anja
    Warth, Arne
    Kamphues, Carsten
    Dietel, Manfred
    Weichert, Wilko
    Klauschen, Frederick
    Wittschieber, Daniel
    [J]. HUMAN PATHOLOGY, 2012, 43 (08) : 1314 - 1321
  • [19] Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK
    Takahashi, C
    Sheng, ZQ
    Horan, TP
    Kitayama, H
    Maki, M
    Hitomi, K
    Kitaura, Y
    Takai, S
    Sasahara, RM
    Horimoto, A
    Ikawa, Y
    Ratzkin, BJ
    Arakawa, T
    Noda, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (22) : 13221 - 13226
  • [20] Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer
    Takenaka, K
    Ishikawa, S
    Kawano, Y
    Yanagihara, K
    Miyahara, R
    Otake, Y
    Morioka, Y
    Takahashi, C
    Noda, M
    Wada, H
    Tanaka, F
    [J]. EUROPEAN JOURNAL OF CANCER, 2004, 40 (10) : 1617 - 1623